M4MM
Neurotech International Enters Development Agreement for Cannabinoid Therapies
LOS ANGELES- Neurotech International Limited, a clinical-stage biopharmaceutical company specializing in pediatric neurological disorders, has signed a development agreement with RH Pharma, a subsidiary of the European Cannabis Company (ECC). This collaboration aims to develop ...
North Carolina Voters Show Strong Support for Medical Cannabis Legalization
LOS ANGELES- A recent poll indicates that a significant majority of North Carolina voters favor the legalization of medical cannabis, with substantial backing across political affiliations. The survey reveals that 45% of respondents "strongly" support ...
Industry Collaboration Essential to Mitigate Cannabis Testing Lab Fraud
LOS ANGELES- The cannabis industry is confronting significant challenges related to fraudulent practices in testing laboratories, including the inflation of THC potency levels and the manipulation of safety results. These actions not only mislead consumers ...
Pakistan Enters Global Hemp Market with Plans for 2025 Cultivation
LOS ANGELES- Pakistan is set to join the global hemp market by allowing commercial cultivation of hemp beginning in January 2025. This strategic move is aimed at enhancing the country’s economy through increased foreign exchange ...
Curaleaf Reports Revenue Growth in Q2 2024
LOS ANGELES- Curaleaf Holdings, Inc. reported a net loss of $49.8 million for Q2 2024, bringing its year-to-date losses to over $100 million. Despite these losses, the company achieved a 2% increase in revenue, reaching ...
Awakn Life Sciences Advances Phase 3 Trial for Alcohol Use Disorder Treatment
LOS ANGELES- Awakn Life Sciences Corp. announced the screening of its first patient for the Phase 3 trial of AWKN-001, a new treatment targeting severe Alcohol Use Disorder (AUD). The trial, known as MORE-KARE, represents ...
The Cannabist Reports Mixed Q2 2024 Results
LOS ANGELES- The Cannabist Company Holdings Inc. (OTC: CBSTF), formerly known as Columbia Care, delivered a mixed performance for Q2 2024. The company reported $125 million in revenue, a 2% sequential increase but a drop ...
Neurotech International Enters Development Agreement for Cannabinoid Therapies
LOS ANGELES- Neurotech International Limited, a clinical-stage biopharmaceutical company specializing in pediatric neurological disorders, has signed a development agreement with RH Pharma, a subsidiary of the European Cannabis Company (ECC). This collaboration aims to develop ...
North Carolina Voters Show Strong Support for Medical Cannabis Legalization
LOS ANGELES- A recent poll indicates that a significant majority of North Carolina voters favor the legalization of medical cannabis, with substantial backing across political affiliations. The survey reveals that 45% of respondents "strongly" support ...
Industry Collaboration Essential to Mitigate Cannabis Testing Lab Fraud
LOS ANGELES- The cannabis industry is confronting significant challenges related to fraudulent practices in testing laboratories, including the inflation of THC potency levels and the manipulation of safety results. These actions not only mislead consumers ...
